The consulting firm on transatlantic life science, Alacrita combined the expertise of two consulting firms on life science performance and named Dr. Simon Turner PhD FRSC as Partner. It is also taking on the venture of Canopus that recently bought the consulting business on life sciences of Transentia.
Canopus is a consulting firm founded by Dr. Turner that specializes in life science while Transentia concentrates on the commercialization of newly developed technologies.
Newly appointed Partner, Dr. Simon Turner, Phd FRSC said, "I am delighted to be joining Alacrita at an exciting stage in its
evolution. There are tremendous synergies between our two businesses, in particular, Alacrita's focus on expertise-based consulting through its network of senior consultants with deep expertise and many years of industry experience. Alacrita has consistently demonstrated its ability to deliver real value to sophisticated life science companies and investors who have needed to supplement their internal capability. I look forward to serving the firm's expanding base of clients and building the business into a top tier consulting firm."
Details regarding the financial part of the dealing were not disclosed.
Join the Conversation